主要机构二季度买了啥又卖了啥？不要看他们怎么说而要看怎么做

FX168财经视频栏目

最近除了我们仍处在财报季中，各大投资机构也开始发布最新的第二季度的持仓报告了，其中桥水和小摩，也就是摩根大通的持仓报告都挺具有代表性的，今天我们就看看这两家机构最新的持仓情况，看看这些大机构的操作情况，相信能给投资者们带来不错的参考和启发。

分享我的交易策略

交易策略分享，说一说自己在交易中的那些神操作吧，你的idea说不定价值百万！

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

塔希提岛
2022-08-17
塔希提岛
高端药械的高定价体系，归根到底是来自患者与家属的强烈渴望，而非来自某个监管机构的规定与授权
对于依靠不可替代临床价值实现高定价的产品，不管是海外DRG还是国内集采，都不会动摇其定价根基
强势买方的崛起，会冲击掉那些容易被替代产品的定价优势，但不足以动摇拥有硬核优势产品的定价权
对于硬核优势产品而言，医保并不足以根本性动摇自己的高定价根基，反而为自己清除“假高端”竞品，使得自己拥有了更好的定价环境
哎呀呀小伙子
2022-08-15
哎呀呀小伙子
桥水和小摩都算是对中国研究比较深的机构，他们的持仓很值得借鉴
先救我她有对象
2022-08-15
先救我她有对象
又到了一年一度的抄作业的时候了，机构的持仓看着对中概股不友好
揭人不揭短
2022-08-15
揭人不揭短
这个时候还在加仓蔚来，那绝对是妥妥的真爱
揭人不揭短
2022-08-15
揭人不揭短
先把芒格埋葬了，然后再让桥水也亏损了，这个阿里巴巴有点猛
玉米地里吃亏
2022-08-15
玉米地里吃亏
中概股看着真的是要被抛弃了，要不然也不会被这样对待

发表看法

13

57

5

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":684457990,"tweetId":"684457990","gmtCreate":1660559922015,"gmtModify":1660690966974,"author":{"id":3571711780449823,"authorId":3571711780449823,"authorIdStr":"3571711780449823","name":"FX168财经视频栏目","avatar":"https://static.tigerbbs.com/ff6b06690add160937516097dd4844b9","vip":6,"userType":6,"introduction":"全球视野的中文财经网站，7*24小时提供全球财经资讯，数据行情等。","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"社区优质创作者：发表过3篇及以上精华帖，且30天内发表过至少一篇精华帖并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.19","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"}}],"starInvestorFlag":false},"themes":[{"themeId":"5f4e0a7185a74ed196abff08008266de","categoryId":"b76d3c59fc044df59779c041b25852a6","name":"分享我的交易策略","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":5f4e0a7185a74ed196abff08008266de}&rnconfig={\"headerBarHidden\": true}","description":"交易策略分享，说一说自己在交易中的那些神操作吧，你的idea说不定价值百万！","image":"https://static.tigerbbs.com/cd8eaff2e99964ab7a80d92cc196fcd3"}],"images":[],"coverImages":[{"img":"https://static.tigerbbs.com/4a6636c138cecb67fb886f099ca9e421","width":"0","height":"0"}],"title":"主要机构二季度买了啥又卖了啥？不要看他们怎么说而要看怎么做","extraTitle":"","html":"<html><head></head><body><p>最近除了我们仍处在财报季中，各大投资机构也开始发布最新的第二季度的持仓报告了，其中桥水和小摩，也就是摩根大通的持仓报告都挺具有代表性的，今天我们就看看这两家机构最新的持仓情况，看看这些大机构的操作情况，相信能给投资者们带来不错的参考和启发。</p><video class=\"ql-video\" controls poster=\"https://static.tigerbbs.com/4a6636c138cecb67fb886f099ca9e421\" playsinline=\"true\" webkit-playsinline=\"true\" tg-width=\"1916\" tg-height=\"1080\"> \n <source src=\"https://1254107296.vod2.myqcloud.com/73ba5544vodgzp1254107296/e1a32dae387702304676536312/ZwHQzNhk1VsA.mp4\" type=\"video/mp4\"> \n</video></body></html>","htmlText":"<html><head></head><body><p>最近除了我们仍处在财报季中，各大投资机构也开始发布最新的第二季度的持仓报告了，其中桥水和小摩，也就是摩根大通的持仓报告都挺具有代表性的，今天我们就看看这两家机构最新的持仓情况，看看这些大机构的操作情况，相信能给投资者们带来不错的参考和启发。</p><video class=\"ql-video\" controls poster=\"https://static.tigerbbs.com/4a6636c138cecb67fb886f099ca9e421\" playsinline=\"true\" webkit-playsinline=\"true\" tg-width=\"1916\" tg-height=\"1080\"> \n <source src=\"https://1254107296.vod2.myqcloud.com/73ba5544vodgzp1254107296/e1a32dae387702304676536312/ZwHQzNhk1VsA.mp4\" type=\"video/mp4\"> \n</video></body></html>","text":"最近除了我们仍处在财报季中，各大投资机构也开始发布最新的第二季度的持仓报告了，其中桥水和小摩，也就是摩根大通的持仓报告都挺具有代表性的，今天我们就看看这两家机构最新的持仓情况，看看这些大机构的操作情况，相信能给投资者们带来不错的参考和启发。","highlighted":2,"essential":2,"paper":2,"likeSize":57,"commentSize":13,"repostSize":5,"favoriteSize":0,"link":"https://laohu8.com/post/684457990","repostId":0,"isVote":1,"tweetType":2,"object":{"id":"c8380288cb7240fea70582383d0e83c0","videoUrl":"https://1254107296.vod2.myqcloud.com/73ba5544vodgzp1254107296/e1a32dae387702304676536312/ZwHQzNhk1VsA.mp4","poster":"https://static.tigerbbs.com/4a6636c138cecb67fb886f099ca9e421","desc":""},"viewCount":14422,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["JPM"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":233,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":7603876,"gmtCreate":1660695950103,"gmtModify":1660699913769,"authorId":3528110373865573,"author":{"id":3528110373865573,"authorId":3528110373865573,"name":"塔希提岛","avatar":"https://static.tigerbbs.com/9c019441f20eb1c346539f210e6050c1","vip":1,"currentWearingBadge":{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.14%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":3,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":684457990,"type":1,"supId":0,"prevId":0,"content":"高端药械的高定价体系，归根到底是来自患者与家属的强烈渴望，而非来自某个监管机构的规定与授权<br>\n对于依靠不可替代临床价值实现高定价的产品，不管是海外DRG还是国内集采，都不会动摇其定价根基<br>\n强势买方的崛起，会冲击掉那些容易被替代产品的定价优势，但不足以动摇拥有硬核优势产品的定价权<br>\n对于硬核优势产品而言，医保并不足以根本性动摇自己的高定价根基，反而为自己清除“假高端”竞品，使得自己拥有了更好的定价环境<br>","text":"高端药械的高定价体系，归根到底是来自患者与家属的强烈渴望，而非来自某个监管机构的规定与授权<br>\n对于依靠不可替代临床价值实现高定价的产品，不管是海外DRG还是国内集采，都不会动摇其定价根基<br>\n强势买方的崛起，会冲击掉那些容易被替代产品的定价优势，但不足以动摇拥有硬核优势产品的定价权<br>\n对于硬核优势产品而言，医保并不足以根本性动摇自己的高定价根基，反而为自己清除“假高端”竞品，使得自己拥有了更好的定价环境<br>","html":"高端药械的高定价体系，归根到底是来自患者与家属的强烈渴望，而非来自某个监管机构的规定与授权<br>\n对于依靠不可替代临床价值实现高定价的产品，不管是海外DRG还是国内集采，都不会动摇其定价根基<br>\n强势买方的崛起，会冲击掉那些容易被替代产品的定价优势，但不足以动摇拥有硬核优势产品的定价权<br>\n对于硬核优势产品而言，医保并不足以根本性动摇自己的高定价根基，反而为自己清除“假高端”竞品，使得自己拥有了更好的定价环境<br>","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":7600968,"gmtCreate":1660563449456,"gmtModify":1660563450505,"authorId":9000000000000158,"author":{"id":9000000000000158,"authorId":9000000000000158,"name":"哎呀呀小伙子","avatar":"https://static.tigerbbs.com/124ddb27832ad3a5d8aa835fe6bb7572","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":684457990,"type":1,"supId":0,"prevId":0,"content":"桥水和小摩都算是对中国研究比较深的机构，他们的持仓很值得借鉴","text":"桥水和小摩都算是对中国研究比较深的机构，他们的持仓很值得借鉴","html":"桥水和小摩都算是对中国研究比较深的机构，他们的持仓很值得借鉴","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":7600967,"gmtCreate":1660563337931,"gmtModify":1660563338896,"authorId":9000000000000687,"author":{"id":9000000000000687,"authorId":9000000000000687,"name":"先救我她有对象","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":684457990,"type":1,"supId":0,"prevId":0,"content":"又到了一年一度的抄作业的时候了，机构的持仓看着对中概股不友好","text":"又到了一年一度的抄作业的时候了，机构的持仓看着对中概股不友好","html":"又到了一年一度的抄作业的时候了，机构的持仓看着对中概股不友好","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":7600960,"gmtCreate":1660563209972,"gmtModify":1660563210973,"authorId":9000000000000220,"author":{"id":9000000000000220,"authorId":9000000000000220,"name":"揭人不揭短","avatar":"https://static.tigerbbs.com/0d1d522df7fd034a47b809b1a57d7176","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":684457990,"type":1,"supId":0,"prevId":0,"content":"这个时候还在加仓蔚来，那绝对是妥妥的真爱","text":"这个时候还在加仓蔚来，那绝对是妥妥的真爱","html":"这个时候还在加仓蔚来，那绝对是妥妥的真爱","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":7600958,"gmtCreate":1660563144070,"gmtModify":1660563145036,"authorId":9000000000000220,"author":{"id":9000000000000220,"authorId":9000000000000220,"name":"揭人不揭短","avatar":"https://static.tigerbbs.com/0d1d522df7fd034a47b809b1a57d7176","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":684457990,"type":1,"supId":0,"prevId":0,"content":"先把芒格埋葬了，然后再让桥水也亏损了，这个阿里巴巴有点猛","text":"先把芒格埋葬了，然后再让桥水也亏损了，这个阿里巴巴有点猛","html":"先把芒格埋葬了，然后再让桥水也亏损了，这个阿里巴巴有点猛","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":7600957,"gmtCreate":1660563111591,"gmtModify":1660563112503,"authorId":9000000000000561,"author":{"id":9000000000000561,"authorId":9000000000000561,"name":"玉米地里吃亏","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":684457990,"type":1,"supId":0,"prevId":0,"content":"中概股看着真的是要被抛弃了，要不然也不会被这样对待","text":"中概股看着真的是要被抛弃了，要不然也不会被这样对待","html":"中概股看着真的是要被抛弃了，要不然也不会被这样对待","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/684457990"}